Immunocore Holdings plc Files 8-K on Financials
Ticker: IMCR · Form: 8-K · Filed: May 7, 2025 · CIK: 1671927
| Field | Detail |
|---|---|
| Company | Immunocore Holdings PLC (IMCR) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: IMCR
TL;DR
IMCR filed an 8-K on May 7th detailing financial results. Check it out.
AI Summary
Immunocore Holdings plc filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Oxfordshire, United Kingdom.
Why It Matters
This 8-K filing provides investors with crucial updates on Immunocore's financial performance and operational status, which can influence investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate material adverse events.
Key Players & Entities
- Immunocore Holdings plc (company) — Registrant
- May 7, 2025 (date) — Date of Report
- England and Wales (jurisdiction) — State or other jurisdiction of incorporation
- 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom (address) — Address of principal executive offices
- + 44 1235 438600 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on May 7, 2025.
Where are Immunocore Holdings plc's principal executive offices located?
The principal executive offices are located at 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom.
What is the company's state of incorporation?
The company is incorporated in England and Wales.
What is the telephone number listed for Immunocore Holdings plc?
The telephone number listed is +44 1235 438600.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Immunocore Holdings plc (IMCR).